URGN · UroGen Pharma Ltd. · Documents
$35.01
+0.86 (+2.52%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$1.71B
Shares
48.88M
Volume · Oct 20
747.78K
Avg daily vol (3M)
891.45K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2021-05-13 | — | |
| DEF 14A | — | 2021-04-28 | 2021-06-07 | |
| DEFA14A | — | 2021-04-28 | — | |
| 8-K | — | 2021-03-18 | — | |
| 10-K | — | 2021-03-18 | 2020-12-31 | |
| 8-K | — | 2021-03-18 | — | |
| 8-K | — | 2021-01-13 | — | |
| 8-K | — | 2021-01-11 | — | |
| 8-K | — | 2020-12-03 | — | |
| 8-K | — | 2020-11-17 | — | |
| 8-K | — | 2020-11-09 | — | |
| 10-Q | — | 2020-11-09 | 2020-09-30 | |
| 8-K | — | 2020-09-09 | 2020-09-03 | |
| 8-K | — | 2020-08-27 | — | |
| 10-Q | — | 2020-08-10 | 2020-06-30 | |
| 8-K | — | 2020-08-10 | — | |
| 8-K | — | 2020-06-10 | 2020-06-08 | |
| 8-K | — | 2020-05-15 | — | |
| 10-Q | — | 2020-05-07 | 2020-03-31 | |
| DEF 14A | — | 2020-04-29 | 2020-06-08 | |
| DEFA14A | — | 2020-04-29 | — | |
| 8-K | — | 2020-04-16 | 2020-04-15 | |
| 8-K | — | 2020-03-23 | 2020-03-20 | |
| 10-K | — | 2020-03-02 | 2019-12-31 |
Showing 101–124 of 124 filings
Key facts
CIK
1668243
CUSIP
M96088105
13F (30d)
14 filings
14 filers
Visit website
Investor relations